Baidu
map

Stroke:急性缺血性卒中、左心室射血分数和窦性心律的关系

2022-01-30 MedSci原创 MedSci原创

近5%的AIS患者LVEF降低且处于窦性心律。根据队列地区和卒中严重程度,抗血栓治疗的临床实践存在显著差异。鉴于这种临床平衡,需要进一步研究来明确该患者群体二级卒中预防的最佳抗血栓治疗方案。

有关急性缺血性卒中(AIS)后左心室射血分数(LVEF)和窦性心律降低的患者的流行病学和二级卒中预防策略的数据十分有限。

近日,心血管疾病领域权威杂志Stroke上发表了一篇研究文章,研究人员试图描述2002年至2018年期间多中心队列中AIS和抗血栓治疗患者LVEF≤40%和窦性心律的患病率。

这是一项多中心、回顾性队列研究,纳入了在大辛辛那提北肯塔基卒中研究中住院的AIS患者和美国4个以医院为基础的学术队列。研究人员进行一期荟萃分析以计算汇总患病率,并进行单变量分析和调整的多变量Logistic回归模型,以确定与AIS出院时抗凝剂治疗相关的人口统计学、临床和超声心动图特征。

在卒中住院期间记录有LVEF的14338名AIS患者中,LVEF≤40%和窦性心律的加权汇总患病率为5.0%(95%CI为4.1-6.0%;I2为84.4%)。在出院后幸存的524名无心脏血栓且既往无抗凝适应症的患者中,200名(38%)患者出院接受抗凝治疗,289名(55%)患者仅接受抗血小板治疗,35名(7%)患者均未接受抗凝治疗。研究人员使用抗凝剂出院的比例存在不同地区的异质性(22% vs. 45%,P<0.0001)。队列地区和美国国立卫生研究院卒中严重程度量表得分>8(比值比为2.0[95%CI为1.1-3.8])在调整分析中是出院时接受抗凝剂治疗的显著独立预测因素。

由此可见,近5%的AIS患者LVEF降低且处于窦性心律。根据队列地区和卒中严重程度,抗血栓治疗的临床实践存在显著差异。鉴于这种临床平衡,需要进一步研究来明确该患者群体二级卒中预防的最佳抗血栓治疗方案。

原始出处:

Anna D. Baker.et al.Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice Patterns.stroke.2022.https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.036706

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-02-03 九针

    Good

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1674760, encodeId=ace416e476019, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Tue Sep 20 09:29:56 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893471, encodeId=b9c618934e1c5, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Aug 04 07:29:56 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806497, encodeId=69b5180649e0a, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jan 10 14:29:56 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189997, encodeId=4cdb118999e29, content=Good, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Thu Feb 03 20:03:27 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413308, encodeId=736f141330864, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476271, encodeId=a10e14e627115, content=<a href='/topic/show?id=1abce558582' target=_blank style='color:#2F92EE;'>#窦性心律#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75585, encryptionId=1abce558582, topicName=窦性心律)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e147265575, createdName=paperyu, createdTime=Tue Feb 01 01:29:56 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189280, encodeId=139a1189280cd, content=杂志Stroke上发表了一篇研究文章,, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Jan 30 12:12:16 CST 2022, time=2022-01-30, status=1, ipAttribution=)]
    2022-01-30 查查佳佳

    杂志Stroke上发表了一篇研究文章,

    0

相关资讯

Neurology:不用RAPID,不用MR,也能识别发病4.5h内的患者

本研究为回顾性多中心研究,采用 CT低灌注-低密度错配识别发病4.5小时内的卒中患者。研究对象为急性缺血性卒中并且已知发病时间的患者。主要结局指标为:CT低灌注-低密度错配识别发病4.5小时内的预测值

JNNP:急性功能性假性卒中与轻度急性缺血性卒中的长期随访比较

每年都有许多患者因怀疑患有急性缺血性中风(AIS)而入住急诊室。有几种情况可以表现为急性中风样症状,其中最常见的是癫痫发作、偏头痛和功能紊乱。后者被称为假性功能性中风(FSM)。虽然AIS患者的预后已

JAHA:血红蛋白浓度与急性缺血性卒中或TIA患者临床结局之间的关系

异常的血红蛋白浓度与更高的全因死亡、不良功能结局、卒中复发和复合血管事件风险相关。该研究的结果表明需要更多设计良好的临床研究来证实血红蛋白浓度与卒中后患者临床结局之间的关系。

阿加曲班治疗急性缺血性卒中中国专家共识指南2021

目前针对AIS发病早期抗凝治疗的随机对照研究显示,多数抗凝药物虽在一定程度上可降低卒中复发率或减少深静脉血栓形成的风险,但同时会增加出血事件的风险。

Radiology:对于急性缺血性卒中患者,这一影像学指标可提示预后!

在急性缺血性卒中(AIS)中,由于局部脑血流的减少,脑组织局部静脉氧饱和度(SvO2)下降。

Stroke:急性缺血性卒中患者内源性脱氧核糖核酸酶活性和无细胞脱氧核糖核酸的临床意义

急性卒中内源性脱氧核糖核酸酶活性和cfDNA的相互作用需要有趣的新诊断和潜在治疗方法。研究人员确认cfDNA与大血管闭塞导致的卒中有害临床过程存在独立关联。

Baidu
map
Baidu
map
Baidu
map